Eitan Amir

24.0k total citations · 6 hit papers
416 papers, 15.4k citations indexed

About

Eitan Amir is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eitan Amir has authored 416 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 259 papers in Oncology, 121 papers in Cancer Research and 111 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eitan Amir's work include Breast Cancer Treatment Studies (70 papers), Cancer Treatment and Pharmacology (52 papers) and Cancer Genomics and Diagnostics (45 papers). Eitan Amir is often cited by papers focused on Breast Cancer Treatment Studies (70 papers), Cancer Treatment and Pharmacology (52 papers) and Cancer Genomics and Diagnostics (45 papers). Eitan Amir collaborates with scholars based in Canada, Spain and Slovenia. Eitan Amir's co-authors include Alberto Ocaña, Boštjan Šeruga, Arnoud J. Templeton, Ian F. Tannock, Francisco Vera-Badillo, Jennifer J. Knox, Mairéad G. McNamara, Paaladinesh Thavendiranathan, Raya Leibowitz‐Amit and Priya Aneja and has published in prestigious journals such as JAMA, Circulation and Nature Communications.

In The Last Decade

Eitan Amir

388 papers receiving 15.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

2014 2.3k citations Arnoud J. Templeton, Mairéad G. McNamara et al. profile →
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

2014 546 citations Arnoud J. Templeton, Olga Ace et al. Cancer Epidemiology Biomarkers & Prevention profile →
Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis

2012 486 citations Eitan Amir et al. profile →
Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis

2017 478 citations Arnoud J. Templeton, Eitan Amir et al. profile →
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer

2015 437 citations Fanny Dupuy, Sébastien Tabariès et al. profile →
Integrating artificial intelligence in drug discovery and early drug development: a transformative approach

2025 33 citations Alberto Ocaña, Atanasio Pandiella et al. profile →

Peers

Countries citing papers authored by Eitan Amir

Since Specialization

Citations

This map shows the geographic impact of Eitan Amir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eitan Amir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eitan Amir more than expected).

Fields of papers citing papers by Eitan Amir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eitan Amir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eitan Amir. The network helps show where Eitan Amir may publish in the future.

Co-authorship network of co-authors of Eitan Amir

This figure shows the co-authorship network connecting the top 25 collaborators of Eitan Amir. A scholar is included among the top collaborators of Eitan Amir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eitan Amir. Eitan Amir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuroinvasive Potential of Monkeypox Virus: A 25-Year Systematic Review 2025 ·Cureus ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eitan Amir, (unknown), Sayed M. Hassan, Azhar Mahmood	2
2	Incident Myocardial Infarction, Heart Failure, and Oncologic Outcomes in Breast Cancer Survivors 2024 ·JACC CardioOncology ·Oscar Calvillo‐Argüelles, Paaladinesh Thavendiranathan, Yue Chen, Jiming Fang, Peter C. Austin, Eitan Amir, Douglas S. Lee, Husam Abdel‐Qadir	0
3	The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review 2024 ·Critical Reviews in Oncology/Hematology ·(unknown), (unknown), Eitan Amir, (unknown), Mark E. Robson, Nour Abuhadra, Yuan Chen, Daniel Shepshelovich, Hadar Goldvaser	0
4	252P Impact of informative censoring on the interpretation of progression-free survival (PFS) estimates in phase III randomized trials (RCT) in metastatic breast cancer (MBC) 2024 ·ESMO Open ·(unknown), (unknown), (unknown), (unknown), John Savill, (unknown), Eitan Amir	0
5	Benefit of adjuvant bisphosphonates in early breast cancer treated with contemporary systemic therapy: A meta-analysis of randomized control trials 2024 ·Heliyon ·Abhenil Mittal, (unknown), (unknown), (unknown), Eitan Amir	1
6	Considerations for the clinical development of immuno-oncology agents in cancer 2023 ·Frontiers in Immunology ·Atanasio Pandiella, Emiliano Calvo, Víctor Moreno, Eitan Amir, Arnoud J. Templeton, Alberto Ocaña	2
7	Copeptin as a Serum Biomarker for Febrile Convulsions 2021 ·(unknown), (unknown), (unknown), Eitan Amir, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
8	Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study 2021 ·Journal of the American Heart Association ·Husam Abdel‐Qadir, (unknown), Limei Zhou, Peter C. Austin, Oscar Calvillo‐Argüelles, Eitan Amir, Douglas S. Lee, Paaladinesh Thavendiranathan	64
9	Impact of high tumor mutational burden in solid tumors and challenges for biomarker application 2020 ·Cancer Treatment Reviews ·Mairéad G. McNamara, Timothy W. Jacobs, Ángela Lamarca, Richard Hubner, Juan W. Valle, Eitan Amir	73
10	Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study 2020 ·npj Breast Cancer ·Mitchell J. Elliott, Marguerite Ennis, Kathleen I. Pritchard, Carol Townsley, (unknown), Christine Elser, Eitan Amir, Philippe L. Bédard, Lakshmi Rao, Vuk Stambolic, Srikala S. Sridhar, Pamela J. Goodwin, David W. Cescon	9
11	Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis 2019 ·JNCI Cancer Spectrum ·Hadar Goldvaser, (unknown), Daniel Shepshelovich, Rinat Yerushalmi, Michal Sarfaty, Domen Ribnikar, Paaladinesh Thavendiranathan, Eitan Amir	16
12	PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis 2019 ·Cancer Treatment Reviews ·(unknown), Eitan Amir, Markus Kuksis, David Hernández‐Barajas, Laura Rodríguez‐Romo, Christopher M. Booth, Francisco Vera-Badillo	29
13	Health status, emergency department visits, and oncologists' feedback: An analysis of secondary endpoints from a randomized phase II geriatric assessment trial 2018 ·Journal of Geriatric Oncology ·Schroder Sattar, Shabbir M.H. Alibhai, Sarah Brennenstuhl, (unknown), Mary Ellen Macdonald, (unknown), (unknown), Raymond Woo-Jun Jang, Eitan Amir, Monika K. Krzyzanowska, Anthony M. Joshua, Johanne Monette, D. Wan-Chow-Wah, Martine Puts	9
14	Absolute benefit from adjuvant chemotherapy in contemporary clinical trials: A systemic review and meta-analysis 2018 ·Cancer Treatment Reviews ·Hadar Goldvaser, Domen Ribnikar, Habeeb Majeed, Alberto Ocaña, Eitan Amir	12
15	Circulating DNA and Survival in Solid Tumors 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Alberto Ocaña, (unknown), Dolores C. Garcı́a-Olmo, Arnoud J. Templeton, Francisco Vera-Badillo, (unknown), Gemma Serrano‐Heras, Verónica Corrales‐Sánchez, Boštjan Šeruga, Fernando Andrés‐Pretel, Atanasio Pandiella, Eitan Amir	31
16	Failures in Phase III: Causes and Consequences 2015 ·Clinical Cancer Research ·Boštjan Šeruga, Alberto Ocaña, Eitan Amir, Ian F. Tannock	61
17	Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis breakdown → 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Arnoud J. Templeton, Olga Ace, Mairéad G. McNamara, Mustafa Al-Mubarak, Francisco Vera-Badillo, Thomas Hermanns, Boštjan Šeruga, Alberto Ocaña, Ian F. Tannock, Eitan Amir	546
18	Vascular Endothelial Growth Factor Pathway Polymorphisms as Prognostic and Pharmacogenetic Factors in Cancer: A Systematic Review and Meta-analysis 2012 ·Clinical Cancer Research ·Lawson Eng, Abul Kalam Azad, Steven Habbous, Junxiong Pang, Wei Xu, Anke H. Maitland‐van der Zee, Sevtap Savas, Helen Mackay, Eitan Amir, Geoffrey Liu	45
19	Claudin-2 Promotes Breast Cancer Liver Metastasis by Facilitating Tumor Cell Interactions with Hepatocytes 2012 ·Molecular and Cellular Biology ·Sébastien Tabariès, Fanny Dupuy, Zhifeng Dong, Anie Monast, Matthew G. Annis, Jonathan Spicer, Lorenzo Ferri, Atilla Ömeroğlu, Mark Basik, Eitan Amir, Mark Clemons, Peter M. Siegel	93
20	p53 Arg72Pro Polymorphism, HPV Status and Initiation, Progression, and Development of Cervical Cancer: A Systematic Review and Meta-Analysis 2012 ·Clinical Cancer Research ·Steven Habbous, Junxiong Pang, Lawson Eng, Wei Xu, Goldie Kurtz, Fei‐Fei Liu, Helen Mackay, Eitan Amir, Geoffrey Liu	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact